BOSTON: A Stunning AI tool making survival prediction of cancer patients has been invented.
According to the sources, medical researchers have developed an artificial intelligence system capable of predicting a cancer patient’s survival odds simply by analyzing a facial photograph.
The breakthrough AI tool predicting cancer survival rate from patient selfie developed by scientists at Mass General Brigham hospital in the United States marks a major milestone in medical technology, with research findings officially published in The Lancet Digital Health journal.
The system operates by estimating a patient’s biological age before forecasting their likelihood of surviving cancer.
While chronological age is determined by birth date, biological age reflects the actual functional age of bodily and mental systems, heavily influenced by genetics, lifestyle, and environmental factors.
Trained on an extensive dataset of over 40 million images, the technology features two distinct algorithms—one evaluating biological age and the other calculating mortality risk based on subtle facial markers.
Experts noted that this represents the first time an AI tool predicting cancer survival rate from patient selfie developed has achieved survival prognosis solely through facial image analysis.
Clinicians believe this innovation could revolutionize non-invasive diagnostic workflows and personalized treatment planning.
As testing expands, the AI tool predicting cancer survival rate from patient selfie developed is expected to provide valuable predictive insights to complement traditional diagnostic methods worldwide.
AI in Combating Life-Threatening Diseases
Note on AI Helping Cure Deadly Diseases: Artificial intelligence is rapidly transforming the global healthcare landscape, particularly in the early detection, prognosis, and treatment of life-threatening illnesses such as cancer, cardiovascular disorders, and neurodegenerative conditions.
Advanced machine learning models can now analyze complex medical imaging, genetic sequences, and subtle physical indicators with unprecedented accuracy and speed, often detecting pathological anomalies long before traditional symptoms manifest.
Beyond diagnostics, AI is radically accelerating drug discovery by predicting molecular interactions and modeling cellular responses, turning processes that previously took years into months.
Furthermore, AI-driven precision medicine allows oncologists to tailor targeted therapies based on a patient’s unique biological signature, significantly improving treatment efficacy and reducing adverse side effects.
ALSO READ: Rising Cancer Cases in Balochistan Raise Massive Concern
As digital health integration deepens, AI stands as one of humanity’s most powerful assets in mitigating global disease burdens and improving patient survival outcomes.
